Analyze Diet
The Lancet. Infectious diseases2020; 20(4); 467-477; doi: 10.1016/S1473-3099(19)30546-8

Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999-2019: an epidemiological investigation.

Abstract: In 2018-19, Borna disease virus 1 (BoDV-1), the causative agent of Borna disease in horses, sheep, and other domestic mammals, was reported in five human patients with severe to fatal encephalitis in Germany. However, information on case frequencies, clinical courses, and detailed epidemiological analyses are still lacking. We report the occurrence of BoDV-1-associated encephalitis in cases submitted to the Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany, and provide a detailed description of newly identified cases of BoDV-1-induced encephalitis. All brain tissues from 56 encephalitis cases from Bavaria, Germany, of putative viral origin (1999-2019), which had been submitted for virological testing upon request of the attending clinician and stored for stepwise diagnostic procedure, were systematically screened for BoDV-1 RNA. Two additional BoDV-1-positive cases were contributed by other diagnostic centres. Positive results were confirmed by deep sequencing, antigen detection, and determination of BoDV-1-reactive antibodies in serum and cerebrospinal fluid. Clinical and epidemiological data from infected patients were collected and analysed. BoDV-1 RNA and bornavirus-reactive antibodies were detected in eight newly analysed encephalitis cases and the first human BoDV-1 isolate was obtained from an unequivocally confirmed human BoDV-1 infection from the endemic area. Six of the eight BoDV-1-positive patients had no record of immunosuppression before the onset of fatal disease, whereas two were immunocompromised after solid organ transplantation. Typical initial symptoms were headache, fever, and confusion, followed by various neurological signs, deep coma, and severe brainstem involvement. Seven of nine patients with fatal encephalitis of unclear cause were BoDV-1 positive within one diagnostic centre. BoDV-1 sequence information and epidemiological analyses indicated independent spillover transmissions most likely from the local wild animal reservoir. BoDV-1 infection has to be considered as a potentially lethal zoonosis in endemic regions with reported spillover infections in horses and sheep. BoDV-1 infection can result in fatal encephalitis in immunocompromised and apparently healthy people. Consequently, all severe encephalitis cases of unclear cause should be tested for bornaviruses especially in endemic regions. German Federal Ministry of Education and Research.
Publication Date: 2020-01-07 PubMed ID: 31924550DOI: 10.1016/S1473-3099(19)30546-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates an infectious virus known as Borna disease virus 1 (BoDV-1), which originated from animals and caused fatal brain inflammation (encephalitis) in humans in Germany between 1999 and 2019. The research provides critical analysis and information regarding the prevalence, clinical progression, and epidemiological patterns of the virus.

Study Methodology

  • Researchers focused on 56 encephalitis subjects from Bavaria, Germany, believed to be of viral origin between 1999 and 2019. The subjects’ brain tissue samples were submitted for viral testing upon request from the attending physician and stored for a step-by-step diagnostic procedure.
  • The researchers methodically screened the brain tissues for the presence of BoDV-1 RNA, a molecule that carries instructions from DNA to control protein synthesis which indicates the presence of the BoDV-1 virus.
  • Two additional BoDV-1-positive cases were included in the investigation, provided by other diagnostic centers.
  • Positive results for BoDV-1 were validated through deep sequencing, antigen detection, and determination of BoDV-1-reactive antibodies in blood serum and cerebrospinal fluid.
  • Researchers collected and analyzed clinical and epidemiological data from the infected patients.

Study Findings

  • The researchers found BoDV-1 RNA and bornavirus-reactive antibodies in eight of the newly analyzed encephalitis cases. The first human BoDV-1 isolate was obtained from a confirmed human BoDV-1 infection from an endemic area.
  • Six out of the eight BoDV-1-positive patients were not recorded as immunocompromised prior to the onset of the disease. However, two patients had become immunocompromised after undergoing solid organ transplantation.
  • Typically, initial symptoms of the BoDV-1 infection included headache, fever, and confusion, which evolved into various neurological signs, deep coma, and severe brainstem involvement.
  • A significant seven out of nine patients with fatal encephalitis of uncertain cause tested positive for BoDV-1 within one diagnostic centre.

Epidemiological Analysis and Conclusions

  • An analysis of the BoDV-1 sequence information and epidemiological data suggested independent spillover transmissions – instances where the virus jumped from animals to humans – likely originating from the local wild animal reservoir.
  • BoDV-1 infection is concluded as a potentially lethal zoonosis (disease that can be transmitted from animals to humans) in endemic regions with reported spillover infections in horses and sheep.
  • The researchers emphasized that BoDV-1 infection can result in fatal encephalitis both in immunocompromised patients and apparently healthy individuals.
  • It was recommended that all severe encephalitis cases of unclear cause should be tested for bornaviruses, especially in regions where the virus is endemic. This study was funded by the German Federal Ministry of Education and Research.

Cite This Article

APA
Niller HH, Angstwurm K, Rubbenstroth D, Schlottau K, Ebinger A, Giese S, Wunderlich S, Banas B, Forth LF, Hoffmann D, Höper D, Schwemmle M, Tappe D, Schmidt-Chanasit J, Nobach D, Herden C, Brochhausen C, Velez-Char N, Mamilos A, Utpatel K, Evert M, Zoubaa S, Riemenschneider MJ, Ruf V, Herms J, Rieder G, Errath M, Matiasek K, Schlegel J, Liesche-Starnecker F, Neumann B, Fuchs K, Linker RA, Salzberger B, Freilinger T, Gartner L, Wenzel JJ, Reischl U, Jilg W, Gessner A, Jantsch J, Beer M, Schmidt B. (2020). Zoonotic spillover infections with Borna disease virus 1 leading to fatal human encephalitis, 1999-2019: an epidemiological investigation. Lancet Infect Dis, 20(4), 467-477. https://doi.org/10.1016/S1473-3099(19)30546-8

Publication

ISSN: 1474-4457
NlmUniqueID: 101130150
Country: United States
Language: English
Volume: 20
Issue: 4
Pages: 467-477
PII: S1473-3099(19)30546-8

Researcher Affiliations

Niller, Hans Helmut
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.
Angstwurm, Klemens
  • Department of Neurology, University of Regensburg, Regensburg, Germany.
Rubbenstroth, Dennis
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany; Institute of Virology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Schlottau, Kore
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Ebinger, Arnt
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Giese, Sebastian
  • Institute of Virology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wunderlich, Silke
  • Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.
Banas, Bernhard
  • Department of Nephrology, Regensburg University Hospital, Regensburg, Germany.
Forth, Leonie F
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Hoffmann, Donata
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Höper, Dirk
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
Schwemmle, Martin
  • Institute of Virology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Tappe, Dennis
  • Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.
Schmidt-Chanasit, Jonas
  • Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Faculty of Mathematics, Informatics and Natural Sciences, University of Hamburg, Hamburg, Germany.
Nobach, Daniel
  • Institute of Veterinary Pathology, Justus-Liebig-University Giessen, Giessen, Germany.
Herden, Christiane
  • Institute of Veterinary Pathology, Justus-Liebig-University Giessen, Giessen, Germany.
Brochhausen, Christoph
  • Institute of Pathology, University of Regensburg, Regensburg, Germany.
Velez-Char, Natalia
  • Institute of Pathology, University of Regensburg, Regensburg, Germany.
Mamilos, Andreas
  • Institute of Pathology, University of Regensburg, Regensburg, Germany.
Utpatel, Kirsten
  • Institute of Pathology, University of Regensburg, Regensburg, Germany.
Evert, Matthias
  • Institute of Pathology, University of Regensburg, Regensburg, Germany.
Zoubaa, Saida
  • Department of Neuropathology, Regensburg University Hospital, Regensburg, Germany.
Riemenschneider, Markus J
  • Department of Neuropathology, Regensburg University Hospital, Regensburg, Germany.
Ruf, Viktoria
  • Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Herms, Jochen
  • Center for Neuropathology and Prion Research, Ludwig-Maximilians-Universität München, Munich, Germany.
Rieder, Georg
  • Department of Neurology, Klinikum Traunstein, Traunstein, Germany.
Errath, Mario
  • Department of Neurology, Klinikum Traunstein, Traunstein, Germany.
Matiasek, Kaspar
  • Section of Clinical & Comparative Neuropathology, Centre for Clinical Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Schlegel, Jürgen
  • Department of Neuropathology, Technical University of Munich, Munich, Germany.
Liesche-Starnecker, Friederike
  • Department of Neuropathology, Technical University of Munich, Munich, Germany.
Neumann, Bernhard
  • Department of Neurology, University of Regensburg, Regensburg, Germany.
Fuchs, Kornelius
  • Department of Neurology, University of Regensburg, Regensburg, Germany.
Linker, Ralf A
  • Department of Neurology, University of Regensburg, Regensburg, Germany.
Salzberger, Bernd
  • Infectious Diseases, Regensburg University Hospital, Regensburg, Germany.
Freilinger, Tobias
  • Department of Neurology, Klinikum Passau, Passau, Germany; Hertie-Institute for Clinical Brain Research, University Tuebingen, Tuebingen, Germany.
Gartner, Lisa
  • Department of Neurology, Klinikum Passau, Passau, Germany.
Wenzel, Jürgen J
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.
Reischl, Udo
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.
Jilg, Wolfgang
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.
Gessner, André
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.
Jantsch, Jonathan
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.
Beer, Martin
  • Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany. Electronic address: martin.beer@fli.de.
Schmidt, Barbara
  • Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.

MeSH Terms

  • Animals
  • Antibodies, Viral / blood
  • Borna Disease / complications
  • Borna Disease / epidemiology
  • Borna Disease / virology
  • Borna disease virus / genetics
  • Encephalitis / etiology
  • Encephalitis / mortality
  • Encephalitis / pathology
  • Germany / epidemiology
  • Horses / genetics
  • Humans
  • RNA, Viral / genetics
  • Sheep / genetics
  • Virus Replication
  • Zoonoses

Citations

This article has been cited 41 times.
  1. Weiss V, Weidinger P, Matt J, Weissenbacher-Lang C, Nowotny N, Weissenböck H. Rustrela Virus-Associated Encephalomyelitis ('Staggering Disease') in Cats from Eastern Austria, 1994-2016.. Viruses 2023 Jul 25;15(8).
    doi: 10.3390/v15081621pubmed: 37631964google scholar: lookup
  2. Ulrich RG, Drewes S, Haring V, Panajotov J, Pfeffer M, Rubbenstroth D, Dreesman J, Beer M, Dobler G, Knauf S, Johne R, Böhmer MM. [Viral zoonoses in Germany: a One Health perspective].. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2023 Jun;66(6):599-616.
    doi: 10.1007/s00103-023-03709-0pubmed: 37261460google scholar: lookup
  3. Allartz P, Hotop SK, Muntau B, Schlaphof A, Thomé-Bolduan C, Gabriel M, Petersen N, Lintzel M, Behrens C, Eggert P, Pörtner K, Steiner J, Brönstrup M, Tappe D. Detection of bornavirus-reactive antibodies and BoDV-1 RNA only in encephalitis patients from virus endemic areas: a comparative serological and molecular sensitivity, specificity, predictive value, and disease duration correlation study.. Infection 2023 May 30;:1-13.
    doi: 10.1007/s15010-023-02048-1pubmed: 37253816google scholar: lookup
  4. Cain M, Ly H. Increasing evidence of human infections by the neurotropic Borna disease virus 1 (BoDV-1).. Virulence 2023 Dec;14(1):2218075.
    doi: 10.1080/21505594.2023.2218075pubmed: 37227785google scholar: lookup
  5. Grosse L, Lieftüchter V, Vollmuth Y, Hoffmann F, Olivieri M, Reiter K, Tacke M, Heinen F, Borggraefe I, Osterman A, Forstner M, Hübner J, von Both U, Birzele L, Rohlfs M, Schomburg A, Böhmer MM, Ruf V, Cadar D, Muntau B, Pörtner K, Tappe D. First detected geographical cluster of BoDV-1 encephalitis from same small village in two children: therapeutic considerations and epidemiological implications.. Infection 2023 Feb 23;:1-16.
    doi: 10.1007/s15010-023-01998-wpubmed: 36821024google scholar: lookup
  6. Huhndorf M, Juhasz J, Wattjes MP, Schilling A, Schob S, Kaden I, Klaß G, Tappe D. Magnetic resonance imaging of human variegated squirrel bornavirus 1 (VSBV-1) encephalitis reveals diagnostic pattern indistinguishable from Borna disease virus 1 (BoDV-1) encephalitis but typical for bornaviruses.. Emerg Microbes Infect 2023 Dec;12(1):2179348.
    doi: 10.1080/22221751.2023.2179348pubmed: 36757188google scholar: lookup
  7. Pörtner K, Wilking H, Frank C, Böhmer MM, Stark K, Tappe D. Risk factors for Borna disease virus 1 encephalitis in Germany - a case-control study.. Emerg Microbes Infect 2023 Dec;12(1):e2174778.
    doi: 10.1080/22221751.2023.2174778pubmed: 36748319google scholar: lookup
  8. Matiasek K, Pfaff F, Weissenböck H, Wylezich C, Kolodziejek J, Tengstrand S, Ecke F, Nippert S, Starcky P, Litz B, Nessler J, Wohlsein P, Baumbach C, Mundhenk L, Aebischer A, Reiche S, Weidinger P, Olofsson KM, Rohdin C, Weissenbacher-Lang C, Matt J, Rosati M, Flegel T, Hörnfeldt B, Höper D, Ulrich RG, Nowotny N, Beer M, Ley C, Rubbenstroth D. Mystery of fatal 'staggering disease' unravelled: novel rustrela virus causes severe meningoencephalomyelitis in domestic cats.. Nat Commun 2023 Feb 4;14(1):624.
    doi: 10.1038/s41467-023-36204-wpubmed: 36739288google scholar: lookup
  9. Eidenschink L, Knoll G, Tappe D, Offner R, Drasch T, Ehrl Y, Banas B, Banas MC, Niller HH, Gessner A, Köstler J, Lampl BMJ, Pregler M, Völkl M, Kunkel J, Neumann B, Angstwurm K, Schmidt B, Bauswein M. IFN-γ-Based ELISpot as a New Tool to Detect Human Infections with Borna Disease Virus 1 (BoDV-1): A Pilot Study.. Viruses 2023 Jan 10;15(1).
    doi: 10.3390/v15010194pubmed: 36680234google scholar: lookup
  10. Bauswein M, Eidenschink L, Knoll G, Neumann B, Angstwurm K, Zoubaa S, Riemenschneider MJ, Lampl BMJ, Pregler M, Niller HH, Jantsch J, Gessner A, Eberhardt Y, Huppertz G, Schramm T, Kühn S, Koller M, Drasch T, Ehrl Y, Banas B, Offner R, Schmidt B, Banas MC. Human Infections with Borna Disease Virus 1 (BoDV-1) Primarily Lead to Severe Encephalitis: Further Evidence from the Seroepidemiological BoSOT Study in an Endemic Region in Southern Germany.. Viruses 2023 Jan 9;15(1).
    doi: 10.3390/v15010188pubmed: 36680228google scholar: lookup
  11. Widerspick L, Steffen JF, Tappe D, Muñoz-Fontela C. Animal Model Alternatives in Filovirus and Bornavirus Research.. Viruses 2023 Jan 4;15(1).
    doi: 10.3390/v15010158pubmed: 36680198google scholar: lookup
  12. Dürrwald R, Kolodziejek J, Oh DY, Herzog S, Liebermann H, Osterrieder N, Nowotny N. Vaccination against Borna Disease: Overview, Vaccine Virus Characterization and Investigation of Live and Inactivated Vaccines.. Viruses 2022 Dec 2;14(12).
    doi: 10.3390/v14122706pubmed: 36560710google scholar: lookup
  13. Kanda T, Tomonaga K. Reverse Genetics and Artificial Replication Systems of Borna Disease Virus 1.. Viruses 2022 Oct 12;14(10).
    doi: 10.3390/v14102236pubmed: 36298790google scholar: lookup
  14. Petzold J, Gartner AM, Malberg S, Link JB, Bücking B, Lierz M, Herden C. Tissue Distribution of Parrot Bornavirus 4 (PaBV-4) in Experimentally Infected Young and Adult Cockatiels (Nymphicus hollandicus).. Viruses 2022 Oct 1;14(10).
    doi: 10.3390/v14102181pubmed: 36298736google scholar: lookup
  15. Zhang Y, Alwin Prem Anand A, Bode L, Ludwig H, Emrich HM, Dietrich DE. Word recognition memory and serum levels of Borna disease virus specific circulating immune complexes in obsessive-compulsive disorder.. BMC Psychiatry 2022 Sep 8;22(1):597.
    doi: 10.1186/s12888-022-04208-3pubmed: 36076225google scholar: lookup
  16. Rubbenstroth D. Avian Bornavirus Research-A Comprehensive Review.. Viruses 2022 Jul 11;14(7).
    doi: 10.3390/v14071513pubmed: 35891493google scholar: lookup
  17. Schlottau K, Feldmann F, Hanley PW, Lovaglio J, Tang-Huau TL, Meade-White K, Callison J, Williamson BN, Rosenke R, Long D, Wylezich C, Höper D, Herden C, Scott D, Hoffmann D, Saturday G, Beer M, Feldmann H. Development of a nonhuman primate model for mammalian bornavirus infection.. PNAS Nexus 2022 Jul;1(3):pgac073.
    doi: 10.1093/pnasnexus/pgac073pubmed: 35860599google scholar: lookup
  18. Rauch J, Steffen JF, Muntau B, Gisbrecht J, Pörtner K, Herden C, Niller HH, Bauswein M, Rubbenstroth D, Mehlhoop U, Allartz P, Tappe D. Human Borna disease virus 1 encephalitis shows marked pro-inflammatory biomarker and tissue immunoactivation during the course of disease.. Emerg Microbes Infect 2022 Dec;11(1):1843-1856.
    doi: 10.1080/22221751.2022.2098831pubmed: 35788177google scholar: lookup
  19. Reinmiedl J, Schulz H, Ruf VC, Hernandez Petzsche MR, Rissland J, Tappe D. Healthcare-associated exposure to Borna disease virus 1 (BoDV-1).. J Occup Med Toxicol 2022 Jun 9;17(1):13.
    doi: 10.1186/s12995-022-00353-3pubmed: 35681207google scholar: lookup
  20. Ochola GO, Li B, Obanda V, Ommeh S, Ochieng H, Yang XL, Onyuok SO, Shi ZL, Agwanda B, Hu B. Discovery of novel DNA viruses in small mammals from Kenya.. Virol Sin 2022 Aug;37(4):491-502.
    doi: 10.1016/j.virs.2022.06.001pubmed: 35680114google scholar: lookup
  21. Hermann P, Zerr I. Rapidly progressive dementias - aetiologies, diagnosis and management.. Nat Rev Neurol 2022 Jun;18(6):363-376.
    doi: 10.1038/s41582-022-00659-0pubmed: 35508635google scholar: lookup
  22. Bode L, Guo Y, Xie P. Molecular epidemiology of human Borna disease virus 1 infection revisited.. Emerg Microbes Infect 2022 Dec;11(1):1335-1338.
    doi: 10.1080/22221751.2022.2065931pubmed: 35437118google scholar: lookup
  23. Bode L, Dietrich DE, Spannhuth CW, Ludwig H. Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses 2021, 13, 539.. Viruses 2022 Feb 28;14(3).
    doi: 10.3390/v14030494pubmed: 35336901google scholar: lookup
  24. Neumann B, Angstwurm K, Linker RA, Knoll G, Eidenschink L, Rubbenstroth D, Schlottau K, Beer M, Schreiner P, Soutschek E, Böhmer MM, Lampl BMJ, Pregler M, Scheiter A, Evert K, Zoubaa S, Riemenschneider MJ, Asbach B, Gessner A, Niller HH, Schmidt B, Bauswein M. Antibodies against viral nucleo-, phospho-, and X protein contribute to serological diagnosis of fatal Borna disease virus 1 infections.. Cell Rep Med 2022 Jan 18;3(1):100499.
    doi: 10.1016/j.xcrm.2021.100499pubmed: 35106511google scholar: lookup
  25. Marty FH, Bettamin L, Thouard A, Bourgade K, Allart S, Larrieu G, Malnou CE, Gonzalez-Dunia D, Suberbielle E. Borna disease virus docks on neuronal DNA double-strand breaks to replicate and dampens neuronal activity.. iScience 2022 Jan 21;25(1):103621.
    doi: 10.1016/j.isci.2021.103621pubmed: 35024577google scholar: lookup
  26. Frank C, Wickel J, Brämer D, Matschke J, Ibe R, Gazivoda C, Günther A, Hartmann C, Rehn K, Cadar D, Mayer TE, Pörtner K, Wilking H, Schmidt-Chanasit J, Tappe D. Human Borna disease virus 1 (BoDV-1) encephalitis cases in the north and east of Germany.. Emerg Microbes Infect 2022 Dec;11(1):6-13.
    doi: 10.1080/22221751.2021.2007737pubmed: 34783638google scholar: lookup
  27. Lee SH, Kim K, Kim J, No JS, Park K, Budhathoki S, Lee SH, Lee J, Cho SH, Cho S, Lee GY, Hwang J, Kim HC, Klein TA, Uhm CS, Kim WK, Song JW. Discovery and Genetic Characterization of Novel Paramyxoviruses Related to the Genus Henipavirus in Crocidura Species in the Republic of Korea.. Viruses 2021 Oct 7;13(10).
    doi: 10.3390/v13102020pubmed: 34696450google scholar: lookup
  28. Kanda T, Horie M, Komatsu Y, Tomonaga K. The Borna Disease Virus 2 (BoDV-2) Nucleoprotein Is a Conspecific Protein That Enhances BoDV-1 RNA-Dependent RNA Polymerase Activity.. J Virol 2021 Oct 13;95(21):e0093621.
    doi: 10.1128/JVI.00936-21pubmed: 34406860google scholar: lookup
  29. Tappe D, Pörtner K, Frank C, Wilking H, Ebinger A, Herden C, Schulze C, Muntau B, Eggert P, Allartz P, Schuldt G, Schmidt-Chanasit J, Beer M, Rubbenstroth D. Investigation of fatal human Borna disease virus 1 encephalitis outside the previously known area for human cases, Brandenburg, Germany - a case report.. BMC Infect Dis 2021 Aug 10;21(1):787.
    doi: 10.1186/s12879-021-06439-3pubmed: 34376142google scholar: lookup
  30. Wildi N, Seuberlich T. Neurotropic Astroviruses in Animals.. Viruses 2021 Jun 23;13(7).
    doi: 10.3390/v13071201pubmed: 34201545google scholar: lookup
  31. Pfaff F, Rubbenstroth D. Two novel bornaviruses identified in colubrid and viperid snakes.. Arch Virol 2021 Sep;166(9):2611-2614.
    doi: 10.1007/s00705-021-05138-3pubmed: 34128103google scholar: lookup
  32. Gifford RJ. Mapping the evolution of bornaviruses across geological timescales.. Proc Natl Acad Sci U S A 2021 Jun 29;118(26).
    doi: 10.1073/pnas.2108123118pubmed: 34088856google scholar: lookup
  33. Arneth B. Leftovers of viruses in human physiology.. Brain Struct Funct 2021 Jul;226(6):1649-1658.
    doi: 10.1007/s00429-021-02306-8pubmed: 34052924google scholar: lookup
  34. Eisermann P, Rubbenstroth D, Cadar D, Thomé-Bolduan C, Eggert P, Schlaphof A, Leypoldt F, Stangel M, Fortwängler T, Hoffmann F, Osterman A, Zange S, Niller HH, Angstwurm K, Pörtner K, Frank C, Wilking H, Beer M, Schmidt-Chanasit J, Tappe D. Active Case Finding of Current Bornavirus Infections in Human Encephalitis Cases of Unknown Etiology, Germany, 2018-2020.. Emerg Infect Dis 2021 May;27(5):1371-1379.
    doi: 10.3201/eid2705.204490pubmed: 33900167google scholar: lookup
  35. Cadar D, Allendorf V, Schulze V, Ulrich RG, Schlottau K, Ebinger A, Hoffmann B, Hoffmann D, Rubbenstroth D, Ismer G, Kibbey C, Marthaler A, Rissland J, Leypoldt F, Stangel M, Schmidt-Chanasit J, Conraths FJ, Beer M, Homeier-Bachmann T, Tappe D. Introduction and spread of variegated squirrel bornavirus 1 (VSBV-1) between exotic squirrels and spill-over infections to humans in Germany.. Emerg Microbes Infect 2021 Dec;10(1):602-611.
    doi: 10.1080/22221751.2021.1902752pubmed: 33706665google scholar: lookup
  36. Hedman HD, Krawczyk E, Helmy YA, Zhang L, Varga C. Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface.. Pathogens 2021 Feb 8;10(2).
    doi: 10.3390/pathogens10020180pubmed: 33567598google scholar: lookup
  37. Ebinger A, Fischer S, Höper D. A theoretical and generalized approach for the assessment of the sample-specific limit of detection for clinical metagenomics.. Comput Struct Biotechnol J 2021;19:732-742.
    doi: 10.1016/j.csbj.2020.12.040pubmed: 33552445google scholar: lookup
  38. Bitschi ML, Bagó Z, Rosati M, Reese S, Goehring LS, Matiasek K. A Systematic Approach to Dissection of the Equine Brain-Evaluation of a Species-Adapted Protocol for Beginners and Experts.. Front Neuroanat 2020;14:614929.
    doi: 10.3389/fnana.2020.614929pubmed: 33390909google scholar: lookup
  39. Schlottau K, Nobach D, Herden C, Finke S, Beer M, Hoffmann D. First isolation, in-vivo and genomic characterization of zoonotic variegated squirrel Bornavirus 1 (VSBV-1) isolates.. Emerg Microbes Infect 2020 Dec;9(1):2474-2484.
    doi: 10.1080/22221751.2020.1847604pubmed: 33151793google scholar: lookup
  40. Bechter K. The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders.. Front Psychiatry 2020;11:773.
    doi: 10.3389/fpsyt.2020.00773pubmed: 32973573google scholar: lookup
  41. Kim KS, Yamamoto Y, Nakaoka S, Tomonaga K, Iwami S, Honda T. Modeling Borna Disease Virus In Vitro Spread Reveals the Mode of Antiviral Effect Conferred by an Endogenous Bornavirus-Like Element.. J Virol 2020 Oct 14;94(21).
    doi: 10.1128/JVI.01204-20pubmed: 32817215google scholar: lookup